{"id":17760,"date":"2026-09-11T12:56:32","date_gmt":"2026-09-11T12:56:32","guid":{"rendered":"https:\/\/veilles-affaires-sociales.fr\/?p=17760"},"modified":"2026-09-11T12:56:32","modified_gmt":"2026-09-11T12:56:32","slug":"la-commission-investit-dans-le-developpement-de-therapeutiques-innovantes-contre-les-virus-respiratoires-titre-traduit-en-francais-par-lia","status":"publish","type":"post","link":"https:\/\/veilles-affaires-sociales.fr\/?p=17760","title":{"rendered":"La Commission investit dans le d\u00e9veloppement de th\u00e9rapeutiques innovantes contre les virus respiratoires.\u00a0(titre traduit en fran\u00e7ais par l&rsquo;IA)"},"content":{"rendered":"<p>La Commission europ\u00e9enne et la Banque europ\u00e9enne d\u2019investissement (BEI) ont conclu un accord d\u2019investissement de 30 millions d\u2019euros avec l\u2019entreprise Ethris. Cet accord vise \u00e0 soutenir le d\u00e9veloppement clinique de traitements et vaccins de nouvelle g\u00e9n\u00e9ration \u00e0 base d\u2019ARN messager (ARNm) contre les virus respiratoires, y compris ceux pr\u00e9sentant un potentiel pand\u00e9mique. Les produits concern\u00e9s seraient administr\u00e9s par inhalation ou spray nasal, directement au point d\u2019entr\u00e9e du pathog\u00e8ne, avec l\u2019objectif de pr\u00e9venir la transmission virale et de renforcer les capacit\u00e9s de pr\u00e9paration et de pr\u00e9vention en cas de pand\u00e9mie.<\/p>\n<p>Cette op\u00e9ration s\u2019inscrit dans le cadre de l\u2019instrument HERA Invest, mis en \u0153uvre par la Commission europ\u00e9enne pour renforcer l\u2019autonomie strat\u00e9gique de l\u2019Union europ\u00e9enne en mati\u00e8re de pr\u00e9paration aux urgences sanitaires. HERA Invest est dot\u00e9 de 130 millions d\u2019euros provenant du programme EU4Health, dans le cadre de l\u2019initiative InvestEU, et cible en particulier les petites et moyennes entreprises. Par l\u2019interm\u00e9diaire de la BEI et en partenariat avec la Commission, il propose des pr\u00eats \u00e0 risque pouvant couvrir jusqu\u2019\u00e0 50 % des co\u00fbts des projets, afin de combler les insuffisances de financement priv\u00e9 et de mobiliser des investissements dans le d\u00e9veloppement de contre-mesures m\u00e9dicales. L\u2019ensemble vise \u00e0 maintenir la capacit\u00e9 de l\u2019Europe \u00e0 faire face \u00e0 de futures menaces sanitaires, en tirant les enseignements de la crise de la COVID-19. (contenu r\u00e9sum\u00e9 en fran\u00e7ais par l&rsquo;IA)\u00a0\u200b<a href=\"https:\/\/health.ec.europa.eu\/latest-updates\/commission-invests-development-innovative-therapeutics-against-respiratory-viruses-2026-09-11_en\" target=\"_blank\" class=\"feedzy-rss-link-icon\">Lire la Suite<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>La Commission europ\u00e9enne et la Banque europ\u00e9enne d\u2019investissement (BEI) ont conclu un accord d\u2019investissement de 30 millions d\u2019euros avec l\u2019entreprise Ethris. Cet accord vise \u00e0 soutenir le d\u00e9veloppement clinique de [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":17753,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[212,7,31],"tags":[258,227,226],"class_list":["post-17760","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gestion-des-crises","category-medicaments-et-produits-de-sante","category-politiques-europeennes-sante-social-travail","tag-hera","tag-ia","tag-sources-etrangeres"],"_links":{"self":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts\/17760","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=17760"}],"version-history":[{"count":0,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts\/17760\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/media\/17753"}],"wp:attachment":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=17760"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=17760"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=17760"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}